PNEUMATIC COMPRESSION DEVICES IN THE HOME SETTING

Similar documents
Medical Policy Original Effective Date: 01/23/2019

Corporate Medical Policy

Pneumatic Compression Pumps for Treatment of Lymphedema and Venous Ulcers

Pneumatic Compression Pumps for Treatment of Lymphedema and Venous Ulcers

Corporate Medical Policy

Protocol. Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

MP Pneumatic Compression Pumps for Treatment of Lymphedema and Venous Ulcers

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

SUBJECT: LIMB PNEUMATIC COMPRESSION EFFECTIVE DATE: 06/27/13 DEVICES FOR VENOUS REVISED DATE: 06/26/14 THROMBOEMBOLISM PROPHYLAXIS

LIMB COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS

SUBJECT: LIMB PNEUMATIC COMPRESSION EFFECTIVE DATE: 06/27/13 DEVICES FOR VENOUS REVISED DATE: 06/26/14, 09/15/15,09/21/17. THROMBOEMBOLISM PROPHYLAXIS

MEDICAL POLICY SUBJECT: LIMB PNEUMATIC COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS

CRYOABLATION OF SOLID TUMORS

Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

URINE DRUG TESTING FOR SUBSTANCE ABUSE TREATMENT AND CHRONIC PAIN MANAGEMENT

VENTRICULAR ASSIST DEVICES AND TOTAL ARTIFICIAL HEARTS

Page: 1 of 13. Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

ADVANCED THERAPIES FOR PHARMACOLOGICAL TREATMENT OF PULMONARY HYPERTENSION

Page: 1 of 14. Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

POSITRON EMISSION TOMOGRAPHY (PET)

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Name of Policy: Lymphedema Pumps/Pneumatic Compression Devices

OSTEOCHONDRAL ALLOGRAFTS AND AUTOGRAFTS IN THE TREATMENT OF FOCAL ARTICULAR CARTILAGE LESIONS

PERCUTANEOUS FACET JOINT DENERVATION

Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

Adam Goldfarb, M.A., D.C., D.E.S.S. Introduction

1. Skin care: Cleansing, lubrication, debriding and administration of antimicrobial therapy.

End-Diastolic Pneumatic Compression Boot as a Treatment of Peripheral Vascular Disease or Lymphedema

Contractor Information

ALLERGY TESTING AND TREATMENT

Clinical Medical Policy Department Clinical Affairs Division DESCRIPTION

ORTHOGNATHIC SURGERY

Premier Health Plan considers Negative Pressure Wound Therapy (NPWT) in the home setting medically necessary for the following indications:

Misunderstandings of Venous thromboembolism prophylaxis

The Standard of Care for Lymphedema: Current Concepts and Physiological Considerations

Venous Insufficiency Ulcers. Patient Assessment: Superficial varicosities. Evidence of healed ulcers. Dermatitis. Normal ABI.

Phlebo Press. Use In: Phlebo Press

Pneumatic Compression Devices and Compression Garments

MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies

Flexitouch System. Advanced Pneumatic Compression Therapy. An Effective At-Home Treatment for Chronic Swelling Associated with Lymphedema

Topical Oxygen Wound Therapy (MEDICAID)

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: MP.015.MH Last Review Date: 11/08/2018 Effective Date: 02/01/2019

MP.015.MH Compression Stockings and Garments

OHTAC Recommendation. Endovascular Laser Treatment for Varicose Veins. Presented to the Ontario Health Technology Advisory Committee in November 2009

To prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban)

Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

Clinical Policy: Dalteparin (Fragmin) Reference Number: CP.PHAR.225

Clinical Policy: Dabigatran (Pradaxa) Reference Number: CP.PMN.49 Effective Date: Last Review Date: 05.18

Bioimpedance Devices for Detection and Management of Lymphedema

Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

Company Introduction

EFFICACY AND COST ANALYSIS OF COMBINED THERMAL, COMPRESSION, DVT PREVENTATIVE THERAPY FOR POST-SURGICAL PATIENTS

Management of Post-Thrombotic Syndrome

End Diastolic Pneumatic Compression Boot as a Treatment of Peripheral Vascular Disease or Lymphedema. Original Policy Date

MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies

MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies

Medicare C/D Medical Coverage Policy

VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Venous Thromboembolism Prophylaxis

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN

What evidence exists that describes the efficacy of mechanical prophylaxis for venous thromboembolism (VTE) in adult surgical patients?

IPC Use in Lymphedema: Physiological Considerations

Venous Thromboembolism. Prevention

Incidence of DVT Post- Hip or Knee Replacement. A Comparison of Incidence at Boundary Trails Health Centre to a Credible Baseline Incidence

Icd 10 code for deep venous

2016 Physician Quality Reporting System Data Collection Form: Total Knee Replacement

Slide 1. Slide 2. Slide 3. Outline of This Presentation

Sympathetic Electrical Stimulation Therapy for Chronic Pain

National Medical Policy

DENOMINATOR: All surgical patients aged 18 years and older undergoing procedures for which VTE prophylaxis is indicated in all patients

VTE Prophylaxis. Serving an unmet need in high-risk acute stroke patients.

Clinical Policy: Dalteparin (Fragmin) Reference Number: ERX.SPA.207 Effective Date:

Pharmacy Prior Authorization

Bioimpedance Devices for Detection and Management of Lymphedema

Onpulse TM technology and the geko TM device: The development of a novel system for the prevention of venous thromboembolism

Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge

First Coast Service Options (FCSO) Medicare Policy Primer

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 66 of 593

Objectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk?

Product Name or Headline

Chronic Venous Insufficiency Compression and Beyond

Local Coverage Article for Chiropractic Services (A47798) Contractor Information. Article Information. Contractor Name. Contractor Numbers

Negative Pressure Wound Therapy (NPWT)

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales

VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies

Transcatheter therapy, venous infusion for thrombolysis, any method, including radiological supervision and interpretation, initial treatment day

MedStar Health, Inc. POLICY AND PROCEDURE MANUAL Policy Number: MP.066.MH Last Review Date: 11/08/2018 Effective Date: 01/01/2019

Icd 10 swelling rule out dvt

VeinOPlus Vascular Peripheral Vascular & Wound Therapy Device

Bioimpedance Devices for Detection and Management of Lymphedema

CY2017 Hospital Outpatient: Vascular Procedure APCs and Complexity Adjustments

Determining Wound Diagnosis and Documentation Tips Job Aid

Anticoagulation for prevention of venous thromboembolism

GENETIC TESTING AND COUNSELING FOR HERITABLE DISORDERS

Policy #: 291 Latest Review Date: February 2013

Quality ID #351: Total Knee Replacement: Venous Thromboembolic and Cardiovascular Risk Evaluation National Quality Strategy Domain: Patient Safety

Transcription:

Status Active Medical and Behavioral Health Policy Section: Medicine Policy Number: II-60 Effective Date: 05/19/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members should not receive specific services based on the recommendation of their provider. These policies govern coverage and not clinical practice. Providers are responsible for medical advice and treatment of patients. Members with specific health care needs should consult an appropriate health care professional. PNEUMATIC COMPRESSION DEVICES IN THE HOME SETTING Description: Pneumatic compression devices consist of an inflatable garment and an electrical pneumatic controller or pump that fills the garment with compressed air. The garment is intermittently inflated and deflated with cycle times and pressures to improve venous circulation and lymphatic drainage. This treatment is also referred to as intermittent pneumatic compression (IPC). Pneumatic compression devices are used in the treatment of lymphedema, chronic venous insufficiency and prevention of venous thromboembolism after major surgery. These devices have also been proposed for use in the home setting in other situations, such as treatment of restless legs syndrome. Many different pneumatic compression devices are available, with varying materials, design, and complexity. These devices are classified into three types: Non-segmented (single compartment) device; Segmented (multi-chamber) device with sequential inflation of each chamber and with fixed pressure (no manual control of pressure) in each chamber; and Segmented (multi-chamber) programmable device with sequential inflation and with manually calibrated pressure in each chamber. Devices cleared by the Food and Drug Administration (FDA) for primary or adjunctive (e.g., post mastectomy) treatment of lymphedema include but are not limited to, the following: Compression Pump, Model GS-128 (Medmark Technologies, LLC., Perkasie, PA) Flexitouch system (Tactile Systems Technology, Inc., Minneapolis, MN) Lympha-Press and Lympha-Press Optimal (Mego Afek, Israel)

PowerPress Unit Sequential Circulator (Hanuri Distribution, Inc., Chatsworth CA) Sequential Circulator (Bio Compression Systems, Inc. Moonachie, NJ) Several pneumatic compression devices are cleared by the FDA for treatment of venous stasis ulcers. Examples include the Model GS- 12, Lympha-press, Flexitouch, and PowerPress Unit listed above as well as Nanotherm (ThermoTek, Inc., Flower Mound, TX), the CTU676 device (Compression Technologies Unlimited, Lansing, MI ) and Recovery+ (Pulsar Scientific LLC, Ludlow, MA). FDA-cleared devices with indications that include prevention of DVT include, but are not limited to, the following: Venowave VW5 (Venowave Inc.; Stouffville, Ontario, Canada): ActiveCare+SFT System (Medical Compression Systems LTD, Or Akiva, Israel) Restep DVT System (Stortford Medical LLC, West Windsor, NJ) Kendall SCD 700 Sequential Compression System (Covidien, Mansfield, MA) Definitions: Lymphedema is the swelling of subcutaneous tissues due to the accumulation of excessive lymph fluid. The accumulation of lymph fluid results from impairment to the normal clearing function of the lymphatic system and/or from an excessive production of lymph. Lymphedema is divided into two broad classes according to etiology. Primary lymphedema is a relatively uncommon, chronic condition which may be due to such causes as Milroy's Disease or congenital anomalies. Secondary lymphedema, which is much more common, results from the destruction of or damage to formerly functioning lymphatic channels, such as surgical removal of lymph nodes or post radiation fibrosis, among other causes. Chronic venous insufficiency (CVI) of the lower extremities is a condition caused by abnormalities of the venous wall and valves, leading to obstruction or reflux of blood flow in the veins. Signs of CVI include hyperpigmentation, stasis dermatitis, chronic edema, and venous ulcers. Venous thromboembolism (VTE) refers to deep vein thrombosis (DVT) or pulmonary embolism (PE). Risk of DVT increases due to venous stasis of the lower limbs as a consequence of immobility during or after surgery. Patients who have major orthopedic surgery (such a total hip arthroplasty, total knee arthroplasty and hip fracture surgery) are at particularly high risk. While most DVTs are asymptomatic and generally resolve when mobility is restored, some acute DVTs can be associated with substantial morbidity. The most serious adverse consequence of an acute DVT is a PE, which

occurs when a DVT detaches and migrates to the lungs. Antithrombotic prophylaxis is recommended for patients undergoing major orthopedic surgery and for other surgical patients at increased risk of VTE. Specialty society guidelines recommend pharmacotherapy unless it is contraindicated. Policy: I. Lymphedema The use of pneumatic compression devices may be considered MEDICALLY NECESSARY for the treatment of lymphedema in the home setting when ALL of the following criteria are met: A. The patient has undergone a four-week trial of conservative therapy which includes: 1. Use of an appropriate compression bandage system or compression garment, 2. Exercise, and 3. Elevation of the limb; B. The treating physician determines that no significant improvement has occurred or significant symptoms remain following the four-week trial. II. Chronic Venous Insufficiency The use of pneumatic compression devices in the home setting may be considered MEDICALLY NECESSARY for the treatment of chronic venous insufficiency of the lower extremities when ALL of the following criteria are met: A. The patient has one or more venous stasis ulcers; B. The patient has undergone a trial of conservative therapy for a minimum of six months which includes ALL of the following: 1. The use of an appropriate compression bandage system or compression garment, 2. Appropriate dressings for the wound, 3. Exercise, and 4. Elevation of the limb. C. The treating physician determines that the venous stasis ulcer has failed to heal. III. Post-Surgical Venous Thromboembolism (VTE) Prophylaxis A. The use of pneumatic compression devices in the home setting may be considered MEDICALLY NECESSARY in patients who have undergone surgery when ALL of the following criteria are met: 1. The patient has undergone surgery that requires postsurgical VTE prophylaxis (e.g., major orthopedic surgery such as such a total hip arthroplasty, total knee arthroplasty or hip fracture repair);

2. The patient has a contraindication to pharmacologic anticoagulants, such as being at high-risk for bleeding. Risk factors for bleeding include: a. Bleeding disorder such as hemophilia b. Active liver disease c. Severe renal failure d. Previous major bleed (and previous bleeding risk similar to current risk) e. Concomitant antiplatelet agent f. History of or difficult-to-control surgical bleeding during the current operative procedure, extensive surgical dissection, and revision surgery. B. Home use of pneumatic compression devices for postsurgical VTE prophylaxis is considered INVESTIGATIVE for all other indications. IV. The use of pneumatic compression devices in the home setting is considered INVESTIGATIVE for all other indications, including but not limited to treatment of restless legs syndrome. Coverage: Blue Cross and Blue Shield of Minnesota medical policies apply generally to all Blue Cross and Blue Plus plans and products. Benefit plans vary in coverage and some plans may not provide coverage for certain services addressed in the medical policies. Medicaid products and some self-insured plans may have additional policies and prior authorization requirements. Receipt of benefits is subject to all terms and conditions of the member s summary plan description (SPD). As applicable, review the provisions relating to a specific coverage determination, including exclusions and limitations. Blue Cross reserves the right to revise, update and/or add to its medical policies at any time without notice. For Medicare NCD and/or Medicare LCD, please consult CMS or National Government Services websites. Refer to the Pre-Certification/Pre-Authorization section of the Medical Behavioral Health Policy Manual for the full list of services, procedures, prescription drugs, and medical devices that require Pre-certification/Pre-Authorization. Note that services with specific coverage criteria may be reviewed retrospectively to determine if criteria are being met. Retrospective denial of claims may result if criteria are not met. Coding: The following codes are included below for informational purposes only, and are subject to change without notice. Inclusion or exclusion of a code does not constitute or imply member coverage or provider reimbursement. HCPCS:

E0650 Pneumatic compressor, non-segmental home model E0651 Pneumatic compressor, segmental home model without calibrated gradient pressure E0652 Pneumatic compressor, segmental home model with calibrated gradient pressure E0655 Non-segmental pneumatic appliance for use with pneumatic compressor, half arm E0656 Segmental pneumatic appliance for use with pneumatic compressor, trunk E0657 Segmental pneumatic appliance for use with pneumatic compressor, chest E0660 Non-segmental pneumatic appliance for use with pneumatic compressor, full leg E0665 Non-segmental pneumatic appliance for use with pneumatic compressor, full arm E0666 Non-segmental pneumatic appliance for use with pneumatic compressor, half leg E0667 Segmental pneumatic appliance for use with pneumatic compressor, full leg E0668 Segmental pneumatic appliance for use with pneumatic compressor, full arm E0669 Segmental pneumatic appliance for use with pneumatic compressor, half leg E0670 Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full legs and trunk E0671 Segmental gradient pressure pneumatic appliance, full leg E0672 Segmental gradient pressure pneumatic appliance, full arm E0673 Segmental gradient pressure pneumatic appliance, half leg E0675 Pneumatic compression device, high pressure, rapid inflation/deflation cycle, for arterial insufficiency (unilateral or bilateral system) E0676 Intermittent limb compression device (includes all accessories), not otherwise specified Policy History: Cross Reference: Developed May 11, 2005 Most recent history: Reviewed February 9, 2011 Reviewed February 8, 2012 Reviewed February 13, 2013 Revised March 12, 2014 Cooling/Heating Devices Used in the Outpatient Setting, VII-14

Current Procedural Terminology (CPT ) is copyright 2013 American Medical Association. All Rights Reserved. No fee schedules, basic units, relative values, or related listings are included in CPT. The AMA assumes no liability for the data contained herein. Applicable FARS/DFARS restrictions apply to government use. Copyright 2014 Blue Cross Blue Shield of Minnesota.